Cardiff Oncology CEO Mani Mohindru acquires 34,364 shares worth $50,002.62
CRDF•CEO buys shares and warrants
Cardiff Oncology CEO Mani Mohindru bought 34,364 common shares at $1.46 each, lifting direct holdings to 59,067 shares.
He also acquired 34,364 common stock purchase warrants with a $1.33 exercise price, holding 34,364 warrants.




